Skip to main content
Journal cover image

Poster: CT-039 Health-Related Quality of Life Following Allogeneic Hematopoietic Stem Cell Transplantation With Omidubicel Versus Standard Umbilical Cord Blood

Publication ,  Conference
Lin, C; Sajeev, G; Stiff, P; Brunstein, C; Cutler, C; Sanz, G; Lindemans, C; Rezvani, A; Hanna, R; Koh, LP; Maziarz, R; Hwang, W; Song, Y ...
Published in: Clinical Lymphoma Myeloma and Leukemia
October 2022

Duke Scholars

Published In

Clinical Lymphoma Myeloma and Leukemia

DOI

ISSN

2152-2650

Publication Date

October 2022

Volume

22

Start / End Page

S185 / S185

Publisher

Elsevier BV

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lin, C., Sajeev, G., Stiff, P., Brunstein, C., Cutler, C., Sanz, G., … Sung, A. (2022). Poster: CT-039 Health-Related Quality of Life Following Allogeneic Hematopoietic Stem Cell Transplantation With Omidubicel Versus Standard Umbilical Cord Blood. In Clinical Lymphoma Myeloma and Leukemia (Vol. 22, pp. S185–S185). Elsevier BV. https://doi.org/10.1016/s2152-2650(22)01142-9
Lin, Chenyu, Gautam Sajeev, Patrick Stiff, Claudio Brunstein, Corey Cutler, Guillermo Sanz, Caroline Lindemans, et al. “Poster: CT-039 Health-Related Quality of Life Following Allogeneic Hematopoietic Stem Cell Transplantation With Omidubicel Versus Standard Umbilical Cord Blood.” In Clinical Lymphoma Myeloma and Leukemia, 22:S185–S185. Elsevier BV, 2022. https://doi.org/10.1016/s2152-2650(22)01142-9.
Lin C, Sajeev G, Stiff P, Brunstein C, Cutler C, Sanz G, et al. Poster: CT-039 Health-Related Quality of Life Following Allogeneic Hematopoietic Stem Cell Transplantation With Omidubicel Versus Standard Umbilical Cord Blood. In: Clinical Lymphoma Myeloma and Leukemia. Elsevier BV; 2022. p. S185–S185.
Lin, Chenyu, et al. “Poster: CT-039 Health-Related Quality of Life Following Allogeneic Hematopoietic Stem Cell Transplantation With Omidubicel Versus Standard Umbilical Cord Blood.” Clinical Lymphoma Myeloma and Leukemia, vol. 22, Elsevier BV, 2022, pp. S185–S185. Crossref, doi:10.1016/s2152-2650(22)01142-9.
Lin C, Sajeev G, Stiff P, Brunstein C, Cutler C, Sanz G, Lindemans C, Rezvani A, Hanna R, Koh LP, Maziarz R, Hwang W, Song Y, Liu Q, Manghani R, Sivaraman S, Signorovitch J, Galamidi-Cohen E, Horwitz M, Sung A. Poster: CT-039 Health-Related Quality of Life Following Allogeneic Hematopoietic Stem Cell Transplantation With Omidubicel Versus Standard Umbilical Cord Blood. Clinical Lymphoma Myeloma and Leukemia. Elsevier BV; 2022. p. S185–S185.
Journal cover image

Published In

Clinical Lymphoma Myeloma and Leukemia

DOI

ISSN

2152-2650

Publication Date

October 2022

Volume

22

Start / End Page

S185 / S185

Publisher

Elsevier BV

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences